The Polo-like kinase Plx1 interacts with and inhibits Myt1 after fertilization of Xenopus eggs

被引:64
|
作者
Inoue, D
Sagata, N
机构
[1] Kyushu Univ, Grad Sch Sci, Dept Biol, Fukuoka 8128581, Japan
[2] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan
来源
EMBO JOURNAL | 2005年 / 24卷 / 05期
关键词
cell cycle; fertilization; Myt1; Plk1; p90(rsk);
D O I
10.1038/sj.emboj.7600567
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
During the meiotic cell cycle in Xenopus oocytes, p90(rsk), the downstream kinase of the Mos - MAPK pathway, interacts with and inhibits the Cdc2 inhibitory kinase Myt1. However, p90(rsk) is inactivated after fertilization due to the degradation of Mos. Here we show that the Polo- like kinase Plx1, instead of p90(rsk), interacts with and inhibits Myt1 after fertilization of Xenopus eggs. At the M phase of the embryonic cell cycle, Cdc2 phosphorylates Myt1 on Thr478 and thereby creates a docking site for Plx1. Plx1 can phosphorylate Myt1 and inhibit its kinase activity both in vitro and in vivo. The interaction between Myt1 and Plx1 is required, at least in part, for normal embryonic cell divisions. Finally, and interestingly, Myt1 is phosphorylated on Thr478 even during the meiotic cell cycle, but its interaction with Plx1 is largely inhibited by p90(rsk)-mediated phosphorylation. These results indicate a switchover in the Myt1 inhibition mechanism at fertilization of Xenopus eggs, and strongly suggest that Plx1 acts as a direct inhibitory kinase of Myt1 in the mitotic cell cycles in Xenopus.
引用
收藏
页码:1057 / 1067
页数:11
相关论文
共 50 条
  • [31] Polo-like kinase 1 as target for cancer therapy
    Weiss, Lily
    Efferth, Thomas
    EXPERIMENTAL HEMATOLGY & ONCOLOGY, 2012, 1
  • [32] Targeting polo-like kinase 1 for cancer therapy
    Klaus Strebhardt
    Axel Ullrich
    Nature Reviews Cancer, 2006, 6 : 321 - 330
  • [33] Polo-like kinase 1 is related with malignant characteristics and inhibits macrophages infiltration in glioma
    Luo, Lin
    Zhang, Xiao-Yang
    Zhen, Ying-Wei
    Guo, Gao-Chao
    Peng, Da-Zhao
    Wei, Cheng
    Pei, Dong-Ling
    Yu, Bin
    Ji, Yu-Chen
    Liu, Xian-Zhi
    Han, Lei
    Zhang, Zhen-Yu
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [34] POLO-LIKE KINASE 1 AS A BIOMARKER IN RECTAL CANCER
    Lim, S. H.
    Shin, J. -S.
    Tut, T. G.
    Ng, W. T. W.
    Chua, W.
    Dissanayake, I. U.
    Spring, K. J.
    Bokey, E. L.
    Ng, W.
    de Souza, P.
    Lee, C. S.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 60 - 60
  • [35] Structural basis for the inhibition of Polo-like kinase 1
    Xu, Jun
    Shen, Chen
    Wang, Tao
    Quan, Junmin
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2013, 20 (09) : 1047 - +
  • [36] Functional Dynamics of Polo-Like Kinase 1 at the Centrosome
    Kishi, Kazuhiro
    van Vugt, Marcel A. T. M.
    Okamoto, Ken-ichi
    Hayashi, Yasunori
    Yaffe, Michael B.
    MOLECULAR AND CELLULAR BIOLOGY, 2009, 29 (11) : 3134 - 3150
  • [37] Structural basis for the inhibition of Polo-like kinase 1
    Jun Xu
    Chen Shen
    Tao Wang
    Junmin Quan
    Nature Structural & Molecular Biology, 2013, 20 : 1047 - 1053
  • [38] Phosphorylation and regulation of PTEN by Polo-like kinase 1
    Choi, Byeong Hyeok
    Lee, Kyung S.
    Dai, Wei
    CANCER RESEARCH, 2012, 72
  • [39] Polo-like kinase 1 promotes pulmonary hypertension
    Rongrong Chen
    Hongfei Wang
    Cuiting Zheng
    Xiyu Zhang
    Li Li
    Shengwei Wang
    Hongyu Chen
    Jing Duan
    Xian Zhou
    Haiyong Peng
    Jing Guo
    Anchen Zhang
    Feifei Li
    Wang Wang
    Yu Zhang
    Jun Wang
    Chen Wang
    Yan Meng
    Xinling Du
    Hongbing Zhang
    Respiratory Research, 24
  • [40] Selective polo-like kinase 1 PBD inhibitor
    Chapagai, Danda P.
    Baxter, Merissa
    Ramamoorthy, Gurusankar
    McInnes, Campbell
    Wyatt, Michael
    CANCER RESEARCH, 2019, 79 (13)